Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

DYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions

NCT: NCT05464147 · COMPLETED

NCT IDNCT05464147
StatusCOMPLETED
Start Date2021-10-19
Completion2025-08-01
SponsorElixir Medical Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

The aim of the DYNAMITE study is to investigate the (a) acute procedural and (b) 9-month follow-up performance of DynamX Drug-Eluting Coronary Bioadaptor System implantation in complex coronary lesions.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑